TNFRSF11B and periodontitis: demonstrated in a mouse model of periodontitis that treatment with AMY-101, administered at a dose of 5 mg/kg, significantly decreased the RANKL/OPG ratio by reducing RANKL levels and increasing OPG expression (42).